Quantcast

Posts related to ‘CBST’

Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Aetna, Sony, ICE, Cubist and More

Investors and traders seem to be constantly looking for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each ...
Read Full Story »
biotech

Top New Biotech Ideas from PropThink

The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise is the ...
Read Full Story »
Wall St Bull statue

Top Wall Street Analyst Upgrades: AllState, Cubist, Beazer and More

Investors and traders are constantly looking for fresh research ideas from Wall Street that will lead to higher income or more profits. We review many fresh research calls to find ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — April 3, 2013: Markets Skid on Jobs and Oil Reports (CBST, CRL, GFI, NEE, CAT, TISI, CAG, MON, SCHN, DDC, GBX, RPM, ZNGA, BAC, FB)

U.S. equity markets opened very slightly higher this morning but it was all downhill from there. The U.S. jobs report from ADP came in weaker than expected and cast a ...
Read Full Story »
Bull and Bear

Top 12 Analyst Upgrades and Downgrades (AU, APO, ASTX, ATML, BSX, CAT, FUN, CRL, CI, CBST, DUK, EMC, GFI, NEE, PNRA, SIX, TUMI, TCB, XEL)

Investors and traders generally stay on the lookout for new ideas that will generate positive returns or income for their portfolio. 24/7 Wall St. looks over numerous research calls to ...
Read Full Story »
biotech

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Big biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. ...
Read Full Story »
biotech

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from ...
Read Full Story »

24/7 Wall St. Closing Bell — October 25, 2012: Markets Off to Good Start, But Lose Steam (CBST, ISIL, FB, BA, BP, ANGI, CLF, CROX, FFV, RRC, RYL, AET, ALK, AN, BG, CL, DNKN, NOV, POT, UAL, AAPL, AMZN, BYI, CLWR, CSTR, DV, HLS, ACI, CMCSA, KKR, MRK, OSK, WY, ZNGA, PSSI, MCK, NYT)

The three major U.S. stock indexes opened higher this morning following the report on new jobless claims, which rose by 369,000, less than the expected 375,000 (our coverage here). In ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AKAM, BCH, BSAC, BA, BP, BRCD, CIEN, CROX, CBST, EMC, FB, HIBB, HON, INTC, ISIL, NBR, NSC)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Thursday. Akamai Technologies Inc. (NASDAQ: AKAM) raised to Outperform at Oppenheimer and ...
Read Full Story »

24/7 Wall St. Closing Bell — August 8, 2012: Markets Get No Energy Today (CBST, RAX, TSLA, PAY, GRPN, DMD, GEVO, PCLN, SZYM, AONE, ANR, CG, CSC, DF, DISH, HFC, M, WFR, RL, AFFY, CTL, CLR, EDMC, JACK, KGC, MNST, AUY, AAP, AMCX, CDTI, HSH, JRCC, RGLD, WEN, DF, SIRI, OWW)

The three major US stock indexes opened lower this morning following on softness in European markets and a mixed close in the Asian markets. There has been little data for ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ARCO, CHD, CVS, CBST, FE, G, GRPN, HCN, IAG, JIVE, MGM, PCLN, PG, RAX, TSLA, PAY, RIMM)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Tuesday morning. Arcos Dorados Holdings Inc. (NYSE: ARCO) started as Neutral at ...
Read Full Story »

Top Analyst Upgrades and Downgrades (BDX, BMC, BP, CBST, DAL, DRIV, DISCA, INTC, JBLU, TECD, UTHR, UAL, WMT)

These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday morning. Becton Dickinson and Co. (NYSE: BDX) cut to Underweight at JPMorgan. ...
Read Full Story »

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the ...
Read Full Story »

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in ...
Read Full Story »

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it ...
Read Full Story »